The Role of Topical Immune Response Modifiers in Skin Cancer

By Woodmansee Courtney   Pillow Jessica   Skinner Robert B.  

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1657-1664

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Tazarotene Cream 0.1% After a Single Dose and After Repeat Topical Applications at Clinical or Exaggerated Application Rates in Patients with Acne Vulgaris or Photodamaged Skin

By Yu Z.   Sefton J.   Lew-Kaya D.A.   Walker P.S.   Yu D.   Tang-Liu D.D-S.  

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 921-929

Adis International

Access to resources Recommend Favorite

Total body topical 5-fluorouracil for extensive non-melanoma skin cancer

By Ruth Serge   Jansman Frank   Sanders Cornelis  

Pharmacy World and Science, Vol. 28, Iss. 3, 2006-06 ,pp. : 159-162

Springer Publishing Company

Access to resources Recommend Favorite

Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons

By Chitwood Katelyn   Etzkorn Jeremy   Cohen George  

Dermatologic Surgery, Vol. 39, Iss. 9, 2013-09 ,pp. : 1306-1316

Elsevier

Access to resources Recommend Favorite

Current and Next Generation Topical Anti-Skin Cancer Therapeutics

By  

Drug Delivery Letters, Vol. 6, Iss. 1, 2016-10 ,pp. : 46-56

Bentham Science Publishers

Access to resources Recommend Favorite